Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myelodysplastic Syndromes 40Leukemia 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Leukemia, Myeloid, Acute 31Lymphoma 29Leukemia, Lymphocytic, Chronic, B-Cell 26Lymphoma, Mantle-Cell 25Lymphoma, Follicular 25Lymphoma, Non-Hodgkin 24Leukemia, Myeloid, Chronic-Phase 24Lymphoma, B-Cell, Marginal Zone 22Leukemia, Myeloid, Accelerated Phase 22Lymphoma, Large B-Cell, Diffuse 21Hodgkin Disease 21Burkitt Lymphoma 21Anemia, Refractory, with Excess of Blasts 21Multiple Myeloma 20Myeloproliferative Disorders 17Lymphoma, Large-Cell, Immunoblastic 17Congenital Abnormalities 17Blast Crisis 17Dendritic Cell Sarcoma, Interdigitating 16Anemia, Refractory 15Recurrence 14Neoplasms, Plasma Cell 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Primary Myelofibrosis 12Leukemia, Biphenotypic, Acute 12Myelodysplastic-Myeloproliferative Diseases 11

Interventions

decitabine and cedazuridine drug combination 1Cord Blood Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Allogeneic Stem Cell Transplantation × Cord Blood Stem Cell Transplantation × Clear all
NCT01092026 2023-12-06

Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells

Universitair Ziekenhuis Brussel

Phase NA Completed
11 enrolled

Allogeneic Stem Cell Transplantation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡